New progress of the roles of NLRP3 inflammasomes in central nervous system diseases

doi:10.13418/j.issn.1001-165x.2022.1.24

PDF(515 KB)

Chinese Journal of Clinical Anatomy ›› 2022, Vol. 40 ›› Issue (1) : 113-116. DOI: 10.13418/j.issn.1001-165x.2022.1.24

New progress of the roles of NLRP3 inflammasomes in central nervous system diseases

Zhang Pengfei¹，Yu Chunze¹，Yu Jianyun²， Yang Li¹*

Author information +

History +

Key words

/ NLRP3 inflammasome / / / Inflammatory response / / / Central nerrous system disease

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

Zhang Pengfei, Yu Chunze, Yu Jianyun, Yang Li. New progress of the roles of NLRP3 inflammasomes in central nervous system diseases[J]. Chinese Journal of Clinical Anatomy. 2022, 40(1): 113-116 https://doi.org/10.13418/j.issn.1001-165x.2022.1.24

References

[1] Zhu S, Ding SY, Wang PH, et al. Nlrp9b inflammasome restricts rotavirus infection in intestinal epithelial cells[J]. Nature, 2017, 546(7660): 667-670. DOI: 10.1038/nature22967.
[2] Karki R, Kanneganti TD. Diverging inflammasome signals in tumorigenesis and potential targeting[J]. Nat Rev Cancer, 2019, 19(4): 197-214. DOI: 10.1038/s41568-019-0123-y.
[3] Liu W, Chen YH, Meng J, et al. Ablation of caspase-1 protects against TBI-induced pyroptosis in vitro and in vivo[J]. J Neuroinflammation, 2018, 15(1): 48. DOI: 10.1186/s12974-018-1083-y.
[4] O'Brien WT, Pham L, Symons GF, et al. The NLRP3 inflammasome in traumatic brain injury: potential as a biomarker and therapeutic target[J]. J Neuroinflammation, 2020, 17(1): 104. DOI: 10.1186/s12974-020-01778-5.
[5] Xu X, Yin DP, Ren HL, et al. Selective NLRP3 inflammasome inhibitor reduces neuroinflammation and improves long-term neurological outcomes in a murine model of traumatic brain injury[J]. Neurobiol Dis, 2018, 117: 15-27. DOI: 10.1016/j.nbd.2018.05.016.
[6] Wallisch JS, Simon DW, Bayir H, et al. Cerebrospinal fluid NLRP3 is increased after severe traumatic brain injury in infants and children[J]. Neurocrit Care, 2017, 27(1): 44-50. DOI: 10.1007/s12028-017-0378-7.
[7] Geng FY, Ma YH, Xing T, et al. Effects of hyperbaric oxygen therapy on inflammasome signaling after traumatic brain injury[J]. Neuroimmunomodulation, 2016, 23(2): 122-129. DOI: 10.1159/000445689.
[8] Severini C, Barbato C, Di Certo MG, et al. Alzheimer's disease: new concepts on the role of autoimmunity and of NLRP3 inflammasome in the pathogenesis of the disease[J]. Curr Neuropharmacol, 2020. DOI: 10.2174/1570159X18666200621204546.
[9] Abbott A. Is 'friendly fire' in the brain provoking Alzheimer's disease[J]? Nature, 2018, 556(7702): 426-428. DOI: 10.1038/d41586-018-04930-7.
[10]Zhang Y, Dong ZF, Song WH. NLRP3 inflammasome as a novel therapeutic target for Alzheimer's disease[J]. Signal Transduct Target Ther, 2020, 5(1): 37. DOI: 10.1038/s41392-020-0145-7.
[11]Ising C, Venegas C, Zhang SS, et al. NLRP3 inflammasome activation drives tau pathology[J]. Nature, 2019, 575(7784): 669-673. DOI: 10.1038/s41586-019-1769-z.
[12]Mao Z, Liu C, Ji S, et al. The NLRP3 inflammasome is involved in the pathogenesis of Parkinson's disease in rats[J]. Neurochem Res, 2017, 42(4): 1104-1115. DOI: 10.1007/s11064-017-2185-0.
[13]Qiao C, Zhang Q, Jiang QL, et al. Inhibition of the hepatic Nlrp3 protects dopaminergic neurons via attenuating systemic inflammation in a MPTP/p mouse model of Parkinson's disease[J]. J Neuroin flammation, 2018, 15(1): 193. DOI: 10.1186/s12974-018-1236-z.
[14]Lee JD, Kumar V, Fung JN, et al. Pharmacological inhibition of complement C5a-C5a1 receptor signalling ameliorates disease pathology in the hSOD1(G93A) mouse model of amyotrophic lateral sclerosis[J]. Br J Pharmacol, 2017, 174(8): 689-699. DOI: 10.1111/bph.13730.
[15]Bellezza I, Grottelli S, Costanzi E, et al. Peroxynitrite activates the NLRP3 inflammasome cascade in SOD1(G93A) mouse model of amyotrophic lateral sclerosis[J]. Mol Neurobiol, 2018, 55(3): 2350-2361. DOI: 10.1007/s12035-017-0502-x.
[16]Inoue M, Williams KL, Gunn MD, et al. NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis[J]. Proc Natl Acad Sci U S A, 2012, 109(26): 10480-10485. DOI: 10.1073/pnas.1201836109.
[17]Zhou KQ, Green CR, Bennet L, et al. The role of connexin and pannexin channels in perinatal bBrain injury and inflammation[J]. Front Physiol, 2019, 10: 141. DOI: 10.3389/fphys.2019.00141.
[18]Zhao J, Piao XY, Wu Y, et al. Cepharanthine attenuates cerebral ischemia/reperfusion injury by reducing NLRP3 inflammasome-induced inflammation and oxidative stress via inhibiting 12/15-LOX signaling[J]. Biomed Pharmacother, 2020, 127: 110151. DOI: 10.1016/j.biopha.2020.110151.
[19]Wang HN, Zhong D, Chen HP, et al. NLRP3 inflammasome activates interleukin-23/interleukin-17 axis during ischaemia-reperfusion injury in cerebral ischaemia in mice[J]. Life Sci, 2019, 227: 101-113. DOI: 10.1016/j.lfs.2019.04.031.
[20]Ye XC, Shen T, Hu JX, et al. Purinergic 2X7 receptor/NLRP3 pathway triggers neuronal apoptosis after ischemic stroke in the mouse[J]. Exp Neurol, 2017, 292: 46-55. DOI: 10.1016/j.expneurol.2017.03.002.
[21]Mohamadi Y, Noori Moghahi SMH, Mousavi M, et al. Intrathecal transplantation of Wharton's jelly mesenchymal stem cells suppresses the NLRP1 inflammasome in the rat model of spinal cord injury[J]. J Chem Neuroanat, 2019, 97: 1-8. DOI: 10.1016/j.jchemneu.2019.01.011.
[22]Su XQ, Wang XY, Gong FT, et al. Oral treatment with glycyrrhizin inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization after traumatic spinal cord injury[J]. Brain Res Bull, 2020, 158: 1-8. DOI: 10.1016/j.brainresbull.2020.02.009.
[23]Wang SN, Guo XY, Tang J, et al. Expression and localization of absent in melanoma 2 in the injured spinal cord[J]. Neural Regen Res, 2019, 14(3): 542-552. DOI: 10.4103/1673-5374.245481.
[24]Ramaswamy V, Walsh JG, Sinclair DB, et al. Inflammasome induction in Rasmussen's encephalitis: cortical and associated white matter pathogenesis[J]. J Neuroinflammation, 2013, 10: 152. DOI: 10.1186/1742-2094-10-152.
[25]Yue J, Wei YJ, Yang XL, et al. NLRP3 inflammasome and endoplasmic reticulum stress in the epileptogenic zone in temporal lobe epilepsy: molecular insights into their interdependence[J]. Neuropathol Appl Neurobiol, 2020, 46(7): 770-785. DOI: 10.1111/nan.12621.
[26]Chen ML, Lin K, Lin SK. NLRP3 inflammasome signaling as an early molecular response is negatively controlled by miR-186 in CFA-induced prosopalgia mice[J]. Braz J Med Biol Res, 2018, 51(9): e7602. DOI: 10.1590/1414-431X20187602.
[27]Zhong ZY, Liang S, Sanchez-Lopez E, et al. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation[J]. Nature, 2018, 560(7717): 198-203. DOI: 10.1038/s41586-018-0372-z.
[28]Christgen S, Place DE, Kanneganti TD. Toward targeting inflammasomes: insights into their regulation and activation[J]. Cell Res, 2020, 30(4): 315-327. DOI: 10.1038/s41422-020-0295-8.
[29]Kelley N, Jeltema D, Duan YH, et al. The NLRP3 inflammasome: an overview of mechanisms of activation and regulation[J]. Int J Mol Sci, 2019, 20(13): 3328. DOI: 10.3390/ijms20133328.
[30]Samir P, Kesavardhana S, Patmore DM, et al. DDX3X acts as a live-or-die checkpoint in stressed cells by regulating NLRP3 inflammasome[J]. Nature, 2019, 573(7775): 590-594. DOI: 10.1038/s41586-019-1551-2.